863444-76-2

Upstream product

• 863444-73-9 4-benzoyloxy-7-[4-fluoro-2-(2-trimethylsilanyl-ethoxymethoxymethyl)-benzyl]-1-methyl-2-oxo-1,2-dihydro-[1,5]naphthyridine-3-carboxylic acid ethyl ester 

Downstream Products

• 926041-45-4 4-benzoyloxy-7-(2-ethylcarbamoyloxymethyl-4-fluoro-benzyl)-1-methyl-2-oxo-1,2-dihydro-[1,5]naphthyridine-3-carboxylic acid ethyl ester 
• 926041-47-6 4-benzoyloxy-7-(2-chloromethyl-4-fluoro-benzyl)-1-methyl-2-oxo-1,2-dihydro-[1,5]naphthyridine-3-carboxylic acid ethyl ester 
• 926041-54-5 7-(2-azidomethyl-4-fluoro-benzyl)-4-benzoyloxy-1-methyl-2-oxo-1,2-dihydro-[1,5]naphthyridine-3-carboxylic acid ethyl ester 
• 863444-79-5 4-benzoyloxy-7-(4-fluoro-2-formyl-benzyl)-1-methyl-2-oxo-1,2-dihydro-[1,5]naphthyridine-3-carboxylic acid ethyl ester 
• 926041-46-5 4-benzoyloxy-7-(4-fluoro-2-methoxymethyl-benzyl)-1-methyl-2-oxo-1,2-dihydro-[1,5]naphthyridine-3-carboxylic acid ethyl ester 

Relevant academic research and scientific papers

HIV INTEGRASE INHIBITORS

The present invention features compounds that are HIV integrase inhibitors and therefore are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.

HIV INTEGRASE INHIBITORS

The present invention features compounds that are HIV integrase inhibitors useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.